|
|
Name: |
Ikarian Capital LLC |
City: |
DALLAS |
State: |
TX |
Zip: |
75201 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
100 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
TARS |
Tarsus Pharmaceuticals, Inc. |
1 |
- |
$0.00 |
$24,916,000 |
485,021 |
8.12% |
-8,732,000 |
-122,668 |
1.095 |
N/A |
|
CRNX |
Crinetics Pharmaceuticals, ... |
2 |
- |
$29.96 |
$17,556,000 |
523,431 |
5.72% |
-8,849,000 |
7,000 |
0.569 |
N/A |
|
SPY |
Standard & Poors Depository... |
3 |
New |
$614.91 |
$13,985,000 |
25,000 |
4.56% |
13,985,000 |
25,000 |
0 |
Closed - End Fund - E... |
|
SRPT |
Sarepta Therapeutics Inc |
4 |
- |
$17.11 |
$10,791,000 |
169,087 |
3.52% |
6,646,000 |
135,000 |
0.177 |
Drug Manufacturers - ... |
|
BPMC |
Blueprint Medicines Corp |
5 |
- |
$128.11 |
$10,082,000 |
113,904 |
3.28% |
-4,691,000 |
-55,470 |
0.173 |
N/A |
|
AKRO |
Akero Therapeutics, Inc. |
6 |
New |
$0.00 |
$9,918,000 |
245,000 |
3.23% |
9,918,000 |
245,000 |
0.325 |
N/A |
|
ALNY |
Alnylam Pharmaceuticals Inc |
7 |
- |
$322.83 |
$8,531,000 |
31,594 |
2.78% |
8,531,000 |
31,594 |
0.026 |
Biotechnology |
|
TGTX |
TG Therapeutics Inc |
8 |
- |
$36.72 |
$8,283,000 |
210,065 |
2.7% |
-483,000 |
-81,175 |
0.163 |
Drug Manufacturers - ... |
|
VRNA |
Verona Pharma Plc |
9 |
- |
$0.00 |
$8,254,000 |
130,000 |
2.69% |
4,539,000 |
50,000 |
0.161 |
N/A |
|
RARE |
Ultragenyx Pharmaceutical Inc |
10 |
- |
$36.52 |
$7,857,000 |
216,989 |
2.56% |
327,000 |
38,000 |
0.236 |
Restaurants |
|
SRRK |
Scholar Rock Holding Corp |
11 |
- |
$35.81 |
$7,850,000 |
244,179 |
2.56% |
-7,588,000 |
-113,006 |
0.282 |
N/A |
|
PCVX |
Vaxcyte, Inc. |
12 |
New |
$0.00 |
$7,552,000 |
200,000 |
2.46% |
7,552,000 |
200,000 |
0.147 |
N/A |
|
VIR |
Vir Biotechnology, Inc. |
13 |
- |
$0.00 |
$6,921,000 |
1,068,062 |
2.25% |
331,000 |
170,200 |
0.838 |
N/A |
|
VRDN |
Viridian Therapeutics Ors Shs |
14 |
- |
$14.33 |
$6,672,000 |
494,949 |
2.17% |
-2,337,000 |
25,000 |
0.55 |
N/A |
|
INSM |
Insmed Inc |
15 |
- |
$99.49 |
$6,469,000 |
84,800 |
2.11% |
-1,802,000 |
-35,000 |
0.045 |
Biotechnology |
|
EWTX |
Edgewise Therapeutics, Inc. |
16 |
New |
$13.17 |
$6,160,000 |
280,000 |
2.01% |
6,160,000 |
280,000 |
0.271 |
N/A |
|
CPRX |
Catalyst Pharmaceutical Par... |
17 |
- |
$21.78 |
$6,054,000 |
249,649 |
1.97% |
-1,243,000 |
-100,000 |
0.241 |
Drugs - Generic |
|
CYTK |
Cytokinetics Inc |
18 |
- |
$33.16 |
$6,028,000 |
149,982 |
1.96% |
-1,027,000 |
0 |
0.109 |
Biotechnology |
|
ELVN |
Enliven Therapeutics Ord Shs |
19 |
- |
$0.00 |
$5,698,000 |
289,538 |
1.86% |
-3,179,000 |
-105,000 |
0.576 |
N/A |
|
PRAX |
Praxis Precision Medicines,... |
20 |
New |
$0.00 |
$5,510,000 |
145,502 |
1.8% |
5,510,000 |
145,502 |
0.278 |
N/A |
|
CDTX |
Cidara Therapeutics, Inc. |
21 |
- |
$49.45 |
$5,362,000 |
248,940 |
1.75% |
3,912,000 |
195,000 |
5.458 |
N/A |
|
ACOG |
Alpha Cognition Inc. |
22 |
- |
$9.11 |
$5,110,000 |
967,867 |
1.66% |
658,000 |
212,000 |
6.232 |
N/A |
|
TECX |
Tectonic Therapeutic Inc |
23 |
- |
$19.80 |
$4,766,000 |
269,090 |
1.55% |
-1,805,000 |
126,762 |
1.827 |
N/A |
|
FBRX |
Forte Biosciences Inc |
24 |
- |
$1.26 |
$4,728,000 |
609,225 |
1.54% |
-9,108,000 |
0 |
1.676 |
N/A |
|
GPCR |
Structure Therapeutics Inc. |
25 |
- |
$21.08 |
$4,571,000 |
264,085 |
1.49% |
-3,133,000 |
-20,000 |
0.419 |
N/A |
|
MTSR |
Metsera, Inc. |
26 |
New |
$28.59 |
$4,083,000 |
150,000 |
1.33% |
4,083,000 |
150,000 |
0.143 |
N/A |
|
STIM |
Neuronetics Inc |
27 |
New |
$3.53 |
$4,048,000 |
1,100,000 |
1.32% |
4,048,000 |
1,100,000 |
4.179 |
N/A |
|
DYN |
Dyne Therapeutics, Inc. |
28 |
New |
$9.57 |
$3,753,000 |
358,837 |
1.22% |
3,753,000 |
358,837 |
0.311 |
N/A |
|
TRVI |
Trevi Therapeutics, Inc. |
29 |
- |
$0.00 |
$3,617,000 |
575,000 |
1.18% |
2,278,000 |
250,000 |
0.565 |
N/A |
|
MAZE |
Maze Therapeutics, Inc. |
30 |
New |
$12.13 |
$3,553,000 |
322,740 |
1.16% |
3,553,000 |
322,740 |
0.737 |
N/A |
|
JANX |
Janux Therapeutics, Inc. |
31 |
- |
$0.00 |
$3,502,000 |
129,691 |
1.14% |
-497,000 |
55,000 |
0.249 |
N/A |
|
ELDN |
Eledon Pharmaceuticals Ord Shs |
32 |
- |
$2.69 |
$3,475,000 |
1,025,221 |
1.13% |
-1,167,000 |
-101,416 |
2.585 |
N/A |
|
BBIO |
Bridgebio Pharma, Inc. |
33 |
- |
$44.86 |
$3,140,000 |
90,837 |
1.02% |
-2,779,000 |
-124,876 |
0.052 |
N/A |
|
CPIX |
Cumberland Pharmaceuticals Inc |
34 |
New |
$2.60 |
$3,130,000 |
740,000 |
1.02% |
3,130,000 |
740,000 |
4.907 |
Drug Manufacturers - ... |
|
KROS |
Keros Therapeutics, Inc. |
35 |
New |
$0.00 |
$2,792,000 |
274,009 |
0.91% |
2,792,000 |
274,009 |
0.668 |
N/A |
|
ABEO |
Abeona Therapeutics Inc |
36 |
- |
$0.19 |
$2,540,000 |
533,581 |
0.83% |
-432,000 |
0 |
0.542 |
Drug Manufacturers - ... |
|
CYBN |
Cybin Inc |
37 |
- |
$8.15 |
$2,518,000 |
397,175 |
0.82% |
-985,000 |
0 |
0.044 |
N/A |
|
IBIO |
Ibio Ord Shs |
38 |
- |
$0.20 |
$2,412,000 |
599,913 |
0.79% |
942,000 |
0 |
0.667 |
Drug Manufacturers - ... |
|
DRUG |
Bright Minds Biosciences Or... |
39 |
- |
$0.00 |
$2,360,000 |
65,431 |
0.77% |
-3,123,000 |
-86,780 |
0.727 |
N/A |
|
EOLS |
Evolus Inc |
40 |
- |
$9.14 |
$2,325,000 |
193,265 |
0.76% |
-1,796,000 |
-180,000 |
0.335 |
N/A |
|
RLAY |
Relay Therapeutics, Inc. |
41 |
- |
$3.30 |
$1,947,000 |
743,308 |
0.63% |
-909,000 |
50,000 |
0.445 |
N/A |
|
LXEO |
Lexeo Therapeutics, Inc. |
42 |
- |
$0.00 |
$1,909,000 |
550,029 |
0.62% |
-1,376,000 |
50,728 |
0 |
N/A |
|
ARCT |
Arcturus Therapeutics Ltd |
43 |
- |
$6.94 |
$1,853,000 |
175,000 |
0.6% |
-1,541,000 |
-25,000 |
0.655 |
N/A |
|
KOD |
Kodiak Sciences Inc. |
44 |
- |
$3.70 |
$1,822,000 |
649,534 |
0.59% |
-3,911,000 |
73,368 |
1.45 |
N/A |
|
ORKA |
Oruka Therapeutics, Inc |
45 |
New |
$11.08 |
$1,795,000 |
175,000 |
0.58% |
1,795,000 |
175,000 |
0.5 |
Diagnostic Substances |
|
APLS |
Apellis Pharmaceuticals Inc |
46 |
- |
$17.43 |
$1,640,000 |
75,000 |
0.53% |
1,525,000 |
71,406 |
0.06 |
N/A |
|
VERV |
Verve Therapeutics, Inc. |
47 |
- |
$0.00 |
$1,638,000 |
358,393 |
0.53% |
679,000 |
188,402 |
0.446 |
N/A |
|
ARVN |
Arvinas Holding Company, Llc |
48 |
New |
$7.54 |
$1,614,000 |
229,900 |
0.53% |
1,614,000 |
229,900 |
0.257 |
N/A |
|
AVTX |
Avalo Therapeutics, Inc |
49 |
- |
$0.43 |
$1,602,000 |
200,000 |
0.52% |
-5,607,000 |
-770,259 |
0.178 |
N/A |
|
VTGN |
Vistagen Therapeutics Inc |
50 |
- |
$1.97 |
$1,504,000 |
601,703 |
0.49% |
1,275,000 |
524,087 |
2.226 |
Biotechnology |
|
RCKT |
Rocket Pharmaceuticals |
51 |
- |
$2.53 |
$1,480,000 |
221,911 |
0.48% |
-1,309,000 |
0 |
0.24 |
N/A |
|
VTYX |
Ventyx Biosciences, Inc. |
52 |
- |
$2.34 |
$1,400,000 |
1,217,590 |
0.46% |
-993,000 |
125,000 |
1.723 |
N/A |
|
RCUS |
Arcus Biosciences Inc |
53 |
- |
$7.95 |
$1,282,000 |
163,363 |
0.42% |
-4,352,000 |
-215,000 |
0.252 |
N/A |
|
DCTH |
Delcath Systems Inc |
54 |
- |
$13.57 |
$1,278,000 |
100,365 |
0.42% |
70,000 |
0 |
0.657 |
Research Services |
|
SGMO |
Sangamo Biosciences Inc |
55 |
- |
$0.52 |
$1,220,000 |
1,860,179 |
0.4% |
-677,000 |
0 |
1.319 |
Biotechnology |
|
VKTX |
Viking Therapeutics, Inc. |
56 |
New |
$26.52 |
$1,208,000 |
50,000 |
0.39% |
1,208,000 |
50,000 |
0.05 |
N/A |
|
TDOC |
Teladoc, Inc. |
57 |
New |
$8.41 |
$1,194,000 |
150,000 |
0.39% |
1,194,000 |
150,000 |
0.103 |
N/A |
|
ALEC |
Alector, Inc. |
58 |
- |
$1.48 |
$1,169,000 |
950,000 |
0.38% |
-627,000 |
0 |
1.199 |
N/A |
|
OKUR |
OnKure Therapeutics, Inc. |
59 |
- |
$2.40 |
$1,091,000 |
253,754 |
0.36% |
-1,091,000 |
0 |
2.006 |
N/A |
|
NUVB |
Nuvation Bio Ord Shs Class A |
60 |
- |
$10.42 |
$1,090,000 |
619,258 |
0.36% |
868,000 |
535,851 |
0.286 |
N/A |
|
NKTR |
Nektar Therapeutics |
61 |
- |
$0.67 |
$1,074,000 |
1,579,528 |
0.35% |
-813,000 |
-449,500 |
0.88 |
Drug Delivery |
|
TRML |
Tourmaline Bio |
62 |
- |
$0.00 |
$1,033,000 |
67,927 |
0.34% |
-345,000 |
0 |
0.164 |
N/A |
|
IMUX |
Immunic Inc |
63 |
- |
$0.70 |
$996,000 |
914,170 |
0.32% |
-618,000 |
-700,000 |
1.015 |
N/A |
|
TERN |
Terns Pharmaceuticals, Inc. |
65 |
- |
$3.83 |
$851,000 |
308,491 |
0.28% |
-858,000 |
0 |
0 |
N/A |
|
SLDB |
Solid Biosciences Inc |
64 |
New |
$4.72 |
$851,000 |
230,000 |
0.28% |
851,000 |
230,000 |
0.963 |
N/A |
|
ETNB |
89bio, Inc. |
66 |
New |
$9.86 |
$727,000 |
100,000 |
0.24% |
727,000 |
100,000 |
0.094 |
N/A |
|
OLMA |
Olema Pharmaceuticals, Inc. |
67 |
- |
$0.00 |
$722,000 |
191,994 |
0.24% |
186,000 |
100,000 |
0.32 |
N/A |
|
VERU |
Veru Inc |
68 |
- |
$0.58 |
$699,000 |
1,425,239 |
0.23% |
84,000 |
480,000 |
2.04 |
Personal Products |
|
LXRX |
Lexicon Pharmaceuticals Inc |
69 |
- |
$0.82 |
$653,000 |
1,417,952 |
0.21% |
-492,000 |
-132,048 |
0.392 |
Diagnostic Substances |
|
GLUE |
Monte Rosa Therapeutics, Inc. |
70 |
- |
$0.00 |
$634,000 |
136,575 |
0.21% |
-1,528,000 |
-175,000 |
0.223 |
N/A |
|
CHRO |
Chromocell Therapeutics Corp |
71 |
New |
$0.00 |
$626,000 |
440,849 |
0.2% |
626,000 |
440,849 |
7.64 |
N/A |
|
PYXS |
Pyxis Oncology, Inc. |
72 |
- |
$0.00 |
$601,000 |
613,253 |
0.2% |
-356,000 |
0 |
1.872 |
N/A |
|
INBX |
Inhibrx Biosciences, Inc. |
73 |
- |
$14.43 |
$589,000 |
42,122 |
0.19% |
-60,000 |
0 |
0.291 |
N/A |
|
FULC |
Fulcrum Therapeutics, Inc. |
74 |
- |
$0.00 |
$576,000 |
200,096 |
0.19% |
-364,000 |
0 |
0.212 |
N/A |
|
SWTX |
Springworks Therapeutics, Inc. |
75 |
- |
$0.00 |
$552,000 |
12,519 |
0.18% |
-804,000 |
-25,000 |
0.015 |
N/A |
|
KZR |
Kezar Life Sciences, Inc. |
76 |
- |
$4.44 |
$522,000 |
106,901 |
0.17% |
-196,000 |
0 |
0.156 |
N/A |
|
PHGE |
BiomX Inc |
77 |
- |
$0.00 |
$496,000 |
892,976 |
0.16% |
-156,000 |
0 |
4.961 |
N/A |
|
LYEL |
Lyell Immunopharma, Inc. |
78 |
- |
$0.44 |
$471,000 |
876,037 |
0.15% |
-346,000 |
-400,000 |
0.361 |
N/A |
|
ITOS |
Iteos Therapeutics, Inc. |
79 |
- |
$0.00 |
$469,000 |
78,585 |
0.15% |
-135,000 |
0 |
0.207 |
N/A |
|
VIGL |
Vigil Neuroscience, Inc. |
80 |
- |
$0.00 |
$445,000 |
250,000 |
0.14% |
-405,000 |
-250,000 |
0.884 |
N/A |
|
AEMD |
Aethlon Medical Inc |
81 |
- |
$0.20 |
$440,000 |
1,229,285 |
0.14% |
-205,000 |
479,285 |
10.168 |
Drug Manufacturers - ... |
|
ANRO |
Alto Neuroscience, Inc. |
82 |
- |
$2.31 |
$378,000 |
175,000 |
0.12% |
-1,103,000 |
-175,000 |
0.651 |
N/A |
|
MNMD |
Mind Medicine |
83 |
- |
$6.55 |
$367,000 |
62,691 |
0.12% |
-69,000 |
0 |
0.077 |
N/A |
|
THRD |
Third Harmonic Bio, Inc. |
84 |
- |
$5.43 |
$347,000 |
100,000 |
0.11% |
-682,000 |
0 |
0.222 |
N/A |
|
DNA |
Ginkgo Bioworks Holdings, Inc |
85 |
New |
$9.46 |
$332,000 |
58,300 |
0.11% |
332,000 |
58,300 |
0.003 |
N/A |
|
TYRA |
Tyra Biosciences, Inc. |
86 |
- |
$0.00 |
$326,000 |
35,000 |
0.11% |
-508,000 |
-25,000 |
0.066 |
N/A |
|
RNAC |
Cartesian Therapeutics, Inc |
88 |
- |
$10.68 |
$292,000 |
22,166 |
0.1% |
-642,000 |
-30,000 |
0 |
N/A |
|
ABOS |
Acumen Pharmaceuticals, Inc. |
87 |
- |
$0.00 |
$292,000 |
265,769 |
0.1% |
-165,000 |
0 |
0.567 |
N/A |
|
SPRB |
Spruce Biosciences, Inc. |
89 |
- |
$0.00 |
$290,000 |
1,000,000 |
0.09% |
-130,000 |
0 |
2.677 |
N/A |
|
ALLK |
Allakos Inc. |
90 |
- |
$0.33 |
$267,000 |
1,171,950 |
0.09% |
-909,000 |
200,000 |
1.375 |
N/A |
|
GERN |
Geron Corporation |
91 |
New |
$1.49 |
$239,000 |
150,000 |
0.08% |
239,000 |
150,000 |
0.028 |
Drug Manufacturers - ... |
|
CMMB |
Chemomab Therapeutics Ameri... |
92 |
- |
$0.00 |
$232,000 |
213,052 |
0.08% |
-154,000 |
0 |
3.124 |
N/A |
|
ACRS |
Aclaris Therapeutics, Inc. |
93 |
- |
$1.47 |
$231,000 |
150,900 |
0.08% |
-637,000 |
-199,100 |
0.204 |
N/A |
|
MNPR |
Monopar Therapeutics |
94 |
- |
$33.60 |
$215,000 |
5,908 |
0.07% |
85,000 |
0 |
0.112 |
Biotechnology |
|
ELYM |
Eliem Therapeutics, Inc. |
95 |
- |
$0.00 |
$214,000 |
175,088 |
0.07% |
-101,000 |
0 |
0.261 |
N/A |
|
PEPG |
Pepgen Inc. |
96 |
New |
$1.15 |
$211,000 |
150,000 |
0.07% |
211,000 |
150,000 |
0.46 |
N/A |
|
ANEB |
Anebulo Pharmaceuticals, Inc. |
97 |
- |
$1.46 |
$205,000 |
157,720 |
0.07% |
-60,000 |
0 |
0.676 |
N/A |
|
VYGR |
Voyager Therapeutics, Inc. |
98 |
- |
$2.96 |
$188,000 |
55,766 |
0.06% |
-128,000 |
0 |
0.149 |
N/A |
|
ELEV |
Elevation Oncology, Inc. |
99 |
- |
$0.36 |
$179,000 |
690,050 |
0.06% |
-209,000 |
0 |
1.167 |
N/A |
|
SNSE |
Sensei Biotherapeutics, Inc. |
100 |
- |
$0.00 |
$177,000 |
449,963 |
0.06% |
-142,000 |
-200,000 |
1.471 |
N/A |
|